Penumbra Inc
(STU:0P8)
€
212.2
2.5 (1.19%)
Market Cap: 8.20 Bil
Enterprise Value: 8.14 Bil
PE Ratio: 266.87
PB Ratio: 7.97
GF Score: 87/100 Penumbra Inc at Wells Fargo Virtual Healthcare Conference Transcript
Sep 09, 2021 / 04:40PM GMT
Release Date Price:
€229
(+0.09%)
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
All right. Good afternoon for those of you on the East Coast, and good morning for those of you on the West Coast. I'm Larry Biegelsen, the medical device analyst. And it's my pleasure to host this session with the management team -- or the CEO, I should say, of Penumbra, Adam Elsesser. In terms of format, it's going to be a fireside chat. (Operator Instructions) We're going to try with the polling questions, which have been going pretty well.
And I think that's it. Adam, thanks for joining us.
Adam Elsesser
Penumbra, Inc. - Co-Founder, Chairman, President & CEO
Yes. Thanks for having us.
Questions & Answers
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
All right. So why don't we jump in start with the COVID question, unfortunately? Next year, hopefully, we won't be asking about COVID. But just I'd love
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot